[Comparative study of 804 CB and phenylbutazone. Double blind test of venous and arterial pathology].
D000328:Adult; D000368:Aged; D000893:Anti-Inflammatory Agents / Q000009:adverse effects / Q000627:therapeutic use*; D003510:Cyclohexanes / Q000009:adverse effects / Q000627:therapeutic use; D003872:Dermatitis / Q000188:drug therapy; D004487:Edema / Q000188:drug therapy; D005260:Female; D006801:Humans; D007651:Keto Acids / Q000009:adverse effects / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D010653:Phenylbutazone / Q000009:adverse effects / Q000627:therapeutic use*; D010654:Phenylbutyrates / Q000009:adverse effects / Q000627:therapeutic use*; D010689:Phlebitis / Q000188:drug therapy*; D012883:Skin Ulcer / Q000188:drug therapy; D013997:Time Factors
D000893:Anti-Inflammatory Agents; D003510:Cyclohexanes; D007651:Keto Acids; D010654:Phenylbutyrates; D010653:Phenylbutazone
Etude comparative du 804 CB et de la phénylbutazone. Essai en double insu en pathologie veineuse et artériolaire